Top compounds associated with response to DHRS7C


Feature Type Standardized
Nominal ANOVA
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.063 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.05
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.071 0.05
mRNA PLX4720 GDSC1000 pan-cancer AAC -0.058 0.05
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.066 0.05
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.064 0.05
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.097 0.05
mRNA MK-2206 GDSC1000 pan-cancer AAC 0.068 0.05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.059 0.06
Download CSV